BMC pediatrics · 2026
A case of neonatal Langerhans cell histiocytosis initially presenting with haemorrhagic vesicles: a case report and literature review.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiang Yang, Qiu Yuan-Xiang, Chen Zhi-Guang, Zhang Liang
Аннотация
BACKGROUND: Neonatal Langerhans cell histiocytosis (LCH) presenting with haemorrhagic vesicles as the initial manifestation is exceedingly rare.
CASE PRESENTATION: A neonate with generalized hemorrhagic vesicles and partial erosion/crusting at birth, The initial differential diagnosis included infections such as syphilis, toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus; however, specific antibody testing for these pathogens in both the mother and infant returned negative results. The diagnosis of LCH was confirmed by dermatological consultation and histopathological examination.The infant was treated with intravenous cefotaxime-sulbactam and topical fusidic acid & hirudoid cream, leading to gradual crusting of haemorrhagic vesicles. Follow-up at 3-4 weeks postpartum showed resolution of skin lesions, with no recurrence observed after 2 months.
CONCLUSIONS: In this study, we documented a unique and notable manifestation of neonatal Langerhans cell histiocytosis.
CASE PRESENTATION: A neonate with generalized hemorrhagic vesicles and partial erosion/crusting at birth, The initial differential diagnosis included infections such as syphilis, toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus; however, specific antibody testing for these pathogens in both the mother and infant returned negative results. The diagnosis of LCH was confirmed by dermatological consultation and histopathological examination.The infant was treated with intravenous cefotaxime-sulbactam and topical fusidic acid & hirudoid cream, leading to gradual crusting of haemorrhagic vesicles. Follow-up at 3-4 weeks postpartum showed resolution of skin lesions, with no recurrence observed after 2 months.
CONCLUSIONS: In this study, we documented a unique and notable manifestation of neonatal Langerhans cell histiocytosis.